Stratec SE/€SBS

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Stratec SE

STRATEC SE, headquartered in Birkenfeld, Germany, specializes in designing and manufacturing fully automated analyzer systems, software, and smart consumables for the in-vitro diagnostics and life sciences sectors. Founded in 1979, the company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on automated analyzer systems for clinical diagnostics and biotechnology clients; the Diatron segment offers systems and consumables for low-throughput hematology and clinical chemistry applications; and the Smart Consumables segment develops polymer-based consumables for diagnostics and medical applications. STRATEC primarily serves as an original equipment manufacturer (OEM), collaborating with diagnostic companies to develop products marketed under their brands. The company's global presence includes facilities in Switzerland, the United States, Romania, Hungary, Austria, and China. Its strategic positioning is reinforced by long-term partnerships with leading in-vitro diagnostics companies and a comprehensive technology portfolio that spans the entire value chain, from design and development to regulatory approval and production. (,)

Ticker

€SBS

Primary listing

XETRA

Industry

Health Care Equipment and Supplies

Employees

1,387

Stratec SE Metrics

BasicAdvanced
€348M
21.72
€1.32
0.49
€0.60
2.10%

Bulls say / Bears say

Stratec SE's acquisition of Natech Plastics in July 2023 enhances its capabilities in producing complex polymer-based consumables, potentially expanding its market reach and product offerings. (Simply Wall St)
The company announced a dividend of €0.55 per share, payable on July 2, 2025, indicating a commitment to returning value to shareholders. (Simply Wall St)
Stratec SE received validation of its climate targets from the Science Based Targets initiative (SBTi) in March 2025, reflecting its commitment to sustainable practices, which may attract ESG-focused investors. (Stock Analysis)
Stratec SE was delisted from the Germany SDAX (Total Return) Index on May 9, 2025, due to the delayed submission of audited financial reports, which may raise concerns about financial transparency. (Simply Wall St)
The company reported a significant decline in earnings per share (EPS) for Q3 2024, with €0.045 compared to €0.42 in Q3 2023, indicating potential profitability challenges. (Simply Wall St)
Stratec SE's stock price has declined by approximately 48.86% over the past year, reflecting potential investor concerns about the company's performance and outlook. (Simply Wall St)
Data summarised monthly by Lightyear AI. Last updated on 1 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SBS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs